Garcia-Castro M, Fuentes-Rios D, Lopez-Romero J, Romero A, Moya-Utrera F, Diaz-Morilla A
Mar Drugs. 2023; 21(12).
PMID: 38132958
PMC: 10744741.
DOI: 10.3390/md21120637.
Wang L, Cai Y, Garssen J, Henricks P, Folkerts G, Braber S
Am J Respir Crit Care Med. 2023; 207(9):1145-1160.
PMID: 36883945
PMC: 10161745.
DOI: 10.1164/rccm.202206-1066TR.
Chen Y, Chen W, Chiang M, Shia B, Wu S
Cancers (Basel). 2022; 14(3).
PMID: 35159065
PMC: 8834375.
DOI: 10.3390/cancers14030798.
Chen Y, Li M, Yu Y, Lin C, Wu S
Cancers (Basel). 2021; 13(18).
PMID: 34572955
PMC: 8467829.
DOI: 10.3390/cancers13184728.
Psomiadou V, Prodromidou A, Galati E, Kostakis I, Maliaros A, Mamais I
Contemp Oncol (Pozn). 2021; 25(1):7-11.
PMID: 33911975
PMC: 8063895.
DOI: 10.5114/wo.2021.105072.
Cancer development in patients with COPD: a retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea.
Ahn S, Lee E, Park B, Jung J, Park J, Sheen S
BMC Pulm Med. 2020; 20(1):170.
PMID: 32539764
PMC: 7296952.
DOI: 10.1186/s12890-020-01194-8.
Energy oversupply to tissues: a single mechanism possibly underlying multiple cancer risk factors.
Wu D, Aktipis A, Pepper J
Evol Med Public Health. 2020; 2019(1):9-16.
PMID: 31893122
PMC: 6379718.
DOI: 10.1093/emph/eoz004.
Whole genome sequencing revealed microbiome in lung adenocarcinomas presented as ground-glass nodules.
Ren Y, Su H, She Y, Dai C, Xie D, Narrandes S
Transl Lung Cancer Res. 2019; 8(3):235-246.
PMID: 31367537
PMC: 6626866.
DOI: 10.21037/tlcr.2019.06.11.
[Oral microbiological diversity in patients with salivary adenoid cystic carcinoma].
Liu X, Yang Q, Gan N, Yang D
Hua Xi Kou Qiang Yi Xue Za Zhi. 2019; 37(3):304-308.
PMID: 31218867
PMC: 7030082.
DOI: 10.7518/hxkq.2019.03.015.
Diaryl hydroxylamines as pan or dual inhibitors of indoleamine 2,3-dioxygenase-1, indoleamine 2,3-dioxygenase-2 and tryptophan dioxygenase.
Winters M, DuHadaway J, Pham K, Lewis-Ballester A, Badir S, Wai J
Eur J Med Chem. 2018; 162:455-464.
PMID: 30469041
PMC: 6318801.
DOI: 10.1016/j.ejmech.2018.11.010.
Relationship between Circulating Inflammation Proteins and Lung Cancer Diagnosis in the National Lung Screening Trial.
Brown D, Zingone A, Yu Y, Zhu B, Candia J, Cao L
Cancer Epidemiol Biomarkers Prev. 2018; 28(1):110-118.
PMID: 30297515
PMC: 6325020.
DOI: 10.1158/1055-9965.EPI-18-0598.
Analysis of the Clinicopathological Characteristics and Risk Factors in Patients with Lung Cancer and Chronic Obstructive Pulmonary Disease.
Miao J, Cai J, Qin X, Liu R
Biomed Res Int. 2018; 2018:8398156.
PMID: 29662900
PMC: 5832198.
DOI: 10.1155/2018/8398156.
HIV as a Cause of Immune Activation and Immunosenescence.
Sokoya T, Steel H, Nieuwoudt M, Rossouw T
Mediators Inflamm. 2017; 2017:6825493.
PMID: 29209103
PMC: 5676471.
DOI: 10.1155/2017/6825493.
Euflammation Attenuates Central and Peripheral Inflammation and Cognitive Consequences of an Immune Challenge after Tumor Development.
Bever S, Liu X, Quan N, Pyter L
Neuroimmunomodulation. 2017; 24(2):74-86.
PMID: 28898868
PMC: 5788296.
DOI: 10.1159/000479184.
The salivary microbiome as an indicator of carcinogenesis in patients with oropharyngeal squamous cell carcinoma: A pilot study.
Wolf A, Moissl-Eichinger C, Perras A, Koskinen K, Tomazic P, Thurnher D
Sci Rep. 2017; 7(1):5867.
PMID: 28725009
PMC: 5517471.
DOI: 10.1038/s41598-017-06361-2.
Development and validation of a prognostic scoring model for Mycobacterium avium complex lung disease: an observational cohort study.
Kumagai S, Ito A, Hashimoto T, Marumo S, Tokumasu H, Kotani A
BMC Infect Dis. 2017; 17(1):436.
PMID: 28629426
PMC: 5477133.
DOI: 10.1186/s12879-017-2544-0.
IDO1 is an Integral Mediator of Inflammatory Neovascularization.
Mondal A, Smith C, DuHadaway J, Sutanto-Ward E, Prendergast G, Bravo-Nuevo A
EBioMedicine. 2016; 14:74-82.
PMID: 27889479
PMC: 5161421.
DOI: 10.1016/j.ebiom.2016.11.013.
Epidemiology of Lung Cancer in Korea: Recent Trends.
Park J, Jang S
Tuberc Respir Dis (Seoul). 2016; 79(2):58-69.
PMID: 27064578
PMC: 4823185.
DOI: 10.4046/trd.2016.79.2.58.
COPD in primary lung cancer patients: prevalence and mortality.
Ytterstad E, Moe P, Hjalmarsen A
Int J Chron Obstruct Pulmon Dis. 2016; 11:625-36.
PMID: 27042050
PMC: 4809346.
DOI: 10.2147/COPD.S101183.
Using Immune Marker Panels to Evaluate the Role of Inflammation in Cancer: Summary of an NCI-sponsored Workshop.
Carrick D, Chaturvedi A, Shiels M, Divi R, Filipski K, Hebert E
Cancer Epidemiol Biomarkers Prev. 2015; 24(9):1427-1433.
PMID: 26108460
PMC: 4690808.
DOI: 10.1158/1055-9965.EPI-14-1419.